Venous thromboembolism (VTE) in cancer patients. ESMO clinical recommendations for prevention and management.

摘要

Venous thromboembolism (VTE) is a major public health issue [1] and one of the most important causes of morbidity and mortality in cancer patients with a negative impact on their quality of life [2]. It has been estimated that VTE is the second leading cause of death in hospitalized and ambulatory cancer patients [3],Most oncologists underestimate the prevalence of VTE and its negative impact on their patients [4]. Furthermore and most important there is evidence that prophylaxis is largely underused in patients at high risk to develop VTE [5] With this background in mind the European Society of Medical Oncology (ESMO) decided to draft recommendations for clinical practice in order to improve perceptions about the magnitude of VTE risk in patients with malignancy and to improve prophylaxis and treatment of VTE in cancer patients among medical oncologists.